ADHD for School Nurses Jackie Tomberlin, MS, RN.

Slides:



Advertisements
Similar presentations
Arianna Ahiagbe ‘12 Human Biology, Sc.B. Thesis Adviser: Bruce Becker, MD, MPH Second Reader: John Marshall, Ph.D. ADHD, INJURY, AND MEDICATION ADHERENCE.
Advertisements

ADD Update Kristi Maroni, MD Lance Feldman, MD, MBA, BSN.
Presented by: Name Month XX, 2012 Is It ADHD or Just Inattention? Insert logo of speaker’s organization Insert host logo Insert local partners’ logo.
Attention Deficit Hyperactivity Disorder
ADHD Diagnosis, Treatment & DSM-5 Considerations Sala S.N. Webb, MD Old Dominion Medical Society June 8, 2013.
Presented to NAMI By Grace Yelland, MD Port Angeles, WA January 15, 2015.
AD/HD General Medical Information Mary Margaret Dagen, M.D. Mary Margaret Dagen, M.D. Westshore Family Medicine Westshore Family Medicine April 24, 2013.
Pharmacological Treatment of Child & Adolescent ADHD.
Attention-Deficit Hyperactivity Disorder in Adults and Children Conceptualization, Diagnosis and Treatment An Integrated Approach By Ghada Hamdan-Allen,
Overview of Mental Health Medications for Children and Adolescents Module 5 ADHD and Disruptive Behavior Disorders 1.
Learners with Attention Deficit Disorder. Brief History  Still's Children with "Detective Moral Control”  Volition-ability to control impulse  Goldstein's.
Psychopharmacology and Developmental Disorders Woodfords Family ServiceKatherine Ray, MD Psychiatry ServicesDouglas Patrick, LCSW PO Box 1768 Portland,
Ghs.org ADHD and the Concussed Athlete S. David Blake, MD Fellow Department of Developmental-Behavioral Pediatrics Children’s Hospital Greenville Hospital.
Drugs for the treatment of Attention-Deficit Hyperactivity Disorder
Attention Deficit Disorder in Children
By: Heather Willis.  Inattention -- A child with ADHD:  Is easily distracted  Does not follow directions or finish tasks  Does not appear to be listening.
ADHD Abnormal Psychology 9a12f f6e86c576a030cc42d e_video.wmvhttp:// 9a12f f6e86c576a030cc42d.
CHILD PSYCHIATRY Fatima Al-Haidar Professor, child & adolescent psychiatrist College of medicine - KSU.
Mahmood Khalil, Ahmad Khatib, Mohammad Khacfe, Ziad Assaf.
ADHD Naturopathic Doctors Ontario
And Alzheimer’s Disease
Treating Depression in the Elderly A Multi-disciplinary Approach 12/11/2003.
ADHD and Psychopharmacology By Monica Robles M.D.
 Sleep changes (insomnia to hypersomnia)  Appetite changes (loss of to over eating)  Arousal changes (lethargic to manic)
FDA Pediatric Advisory Committee June 30, 2005 Marsha D. Rappley, MD.
The Role of the Primary Care Provider in the Diagnosis and Treatment of Attention Deficit / Hyperactivity Disorder Carla M. Thacker PAS 646 March 22, 2007.
Components of a Comprehensive ADHD Treatment Plan Jennifer A. Ganem MS, APRN Londonderry Square 50 Nashua Road, Suite 208 Londonderry, NH (603)
Developmental Disorders
Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.
It Was first discovered by a British Doctor and was called “Defect of Moral Control” Symptoms now associated with ADHD were documented and given a diagnosis.
Lyn Billington June 2006 Treatment of Attention Deficit/Hyperactivity Disorder Lyn Billington Deputy Pharmacy Manager Latrobe Regional Hospital.
1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 20 CENTRAL NERVOUS SYSTEM STIMULANTS.
Child Psychopathology Learning Disorders and Peers Attention Disorders Diagnostic Criteria for ADHD Assessment and theories Reading: Chapter 5.
Drugs used in treatment of addiction
Part 2 ADHD. Parents may first notice that their child loses interest in things sooner than other kids, or seems constantly “out of control” Often teachers.
CONDUCT DISORDER By: Takiyah King. Background The IQ debate The IQ debate Impulse control Impulse control Response Inhibition Response Inhibition.
Drew Yanke M.A. TLLP …A medical condition characterized by inattention and/or hyperactivity-impulsivity One of the most common.
ADHD MEDICATIONS Myths and Facts ADHD Awareness Day, Oct 2011 by Theresa Cerulli, M.D. Neuropsychiatrist.
Dr TG Magagula 13 August Behavioral disorder: noise-making, motor driven.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 16 Central Nervous System Stimulants and Related.
MEDICATION TREATMENT OF ADHD CSNO Conference February 9, 2013 Thomas S. Jensen, MD Sorrento Valley Road, Suite 390 San Diego, CA /
Neurodevelopmental Disorders
Guidelines and Treatment Updates in the Diagnosis and Management of Attention Deficit Hyperactivity Disorder (ADHD) MNPA Fall Conference Freeport, ME November.
BIPOLAR DISEASE IN CHILDREN AND YOUNG ADOLESCENTS By Priya Modi and Kojo Koranteng and Aarushi Sharma.
Attention Deficit Hyperactivity Disorder (ADHD). Definition Attention deficit hyperactivity disorder; a disorder characterized by a persistent pattern.
Pharmacological Manipulation of the Nervous System Treatment vs. Enhancement By: David Hall 9/27/2007.
Chapter – 27 ATTENTION DEFICIT HYPERACTIVITY DISORDER.
ADHD 9 th dec Dr. Sami Adil. ADHD is a neuropsychiatric condition starting since childhood characterized by diminished sustained attention, and.
Child Psychopathology Learning Disability Interventions Videotape Attention Deficits Chapter 5.
What are they and how many people are affected? What are they? Behavior patterns or mental processes that cause serious personal suffering or interfere.
ADHD. What is ADHD?  Attention Deficit Hyperactivity Disorder  Developmental behavioural disorder characterised by:  1. Hyperactivity  2. Poor attention.
STIMLUANTS FOR ADHD Part I Stephen Soltys MD Professor and Chair SIU Department of Psychiatry Double click speaker on subsequent slides.
Chapter 7 Children with Attention Deficit/Hyperactive Disorders (ADHD) © Cengage Learning. All rights reserved.
What is ADHD? Attention Deficit Hyperactivity Disorder By Marcy Greenfield, English 106.
OT 460A. Transition, learning and growth Physical, emotional, and social changes Movement in and out of new and old roles Dichotomy: Need to learn to.
P EDIATRIC ADHD E VALUATIONS AT FMC. ADHD C RITERIA DSM 5 Children must have ≥ 6 sxs from either or both the inattentive and the hyperactivity and impulsivity.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
Attention Deficit- Hyperactivity Disorder... A Closer Look Presented by Belinda Ingram, School Counselor West Bainbridge Elementary School.
Students with Attention Deficit- Hyperactivity Disorder
Disorders of Childhood and Adolescence
ATOMOXETINE, CLONIDINE AND GUANFACINE FOR ADHD
ADHD.
Attention-Deficit/ Hyperactivity Disorder
Attention Defecit Hyperactivity Disorder
Conceptual Framework – Roy’s Theory of Adaptation
Overview of Presentation
CNS Stimulants Defination
CNS Stimulants: Uses (p. 210)
Treatment of Childhood Disorders
Attention Deficit Hyperactivity Disorder
Presentation transcript:

ADHD for School Nurses Jackie Tomberlin, MS, RN

Why does ADHD matter? ADHD is the most common childhood-onset psychological disorder, estimated to affect 5- 7% of children world-wide. It has been shown to have significant impact on multiple domains of quality of life in children and adolescents.

Why does ADHD matter? Self esteem—negative beliefs about self Leads to maladaptive coping strategies (avoidance, procrastination, acting out) Social function—poor peer relationships, family conflict, risky early sexual behavior, bullying, substance abuse

Do you know this child? Hyperactive, distractible, impulsive Underachieving in school Disruptive and often in trouble Socially unsuccessful Can concentrate on things they find interesting or fun Cannot concentrate on tedious or complex

TRENDS Boys 4X more likely to be diagnosed than girls Found in every culture Lower grades, more delinquency, arrests, aggression, injuries, hospitalizations, truancy, failed jobs and relationships

CAUSES Unknown, but strong suggestion of a faulty dopamine transporter 76% risk appears familial (primary relatives have a 5-7X higher risk of having ADHD) Head injury, lead or other environmental exposure Maternal smoking, ETOH, prematurity thought to contribute

BRAIN STUDY Pre-frontal cortex inhibits and directs executive function: planning, prioritization, organization, impulse control Pre-frontal cortex development in children with ADHD is 3 years delayed on average ADHD is a developmental delay in impulse control, concentration, organization Pre-frontal cortex is last to develop and most sensitive to perinatal insults

CONTROVERSIAL IDEAS Elimination diets (inflammation, autoimmune, Whole30) Sugar Food dyes Lack of outdoor time (Nature Deficit Disorder) and natural sunlight Dysfunctional parenting—no limits, chaos

OTHER DIAGNOSES THAT LOOK LIKE ADHD Seizure disorders Sleep disorders Hearing or vision problems Medical disorders (thyroid, illnesses) PTSD, anxiety, depression, substance abuse Learning or cognitive disability ODD present up to 75% in children w/ ADHD/ LD present in 20-30% of children w/ ADHD Tics present 35-90% Disruptive Mood Disorder is new DSM 5 dx: severe, chronic irritability, frequent temper outbursts

TREATMENT Results of MTA study guide treatment Pharmacological and non pharmacological treatments 579 children 7-10 yrs were enrolled in one of 4 study options for 14 months 1)meds alone (ritalin 3X day) 2) Behavioral tx only 3) combo 4) no tx Combo tx and meds alone best Anxiety, academic performance, oppositionality, parent-child relations social skills were better w/ combo therapy Combo tx resulted in successful tx on lower doses of ritalin Early treatment response predicted outcome, higher SES better outcome, maternal depression poorer outcome, low IQ poorer Children w/ ADHD did worse than normal controls on 91% of variables tested

MEDICATIONS STIMULANTS: methylphenidate (Ritalin) amphetamine

MEDICATIONS NON-STIMULANTS: atomoxetine buproprion tri-cyclic anti-depressants guanfacine, clonidine, intuniv modafinil (Provigil)

STIMULANTS Dopamine and norepinepherine re-uptake inhibitors in the pre-frontal cortex Pre-frontal cortex is the “filter”—helps to attend to important things, ignore unimportant Stimulants activate the pre-frontal cortex and aid filter skills and executive function skills

STIMULANTS Goal is to improve distractibility, hyperactivity, impulsivity FDA indicated to treat ADHD Methylphenidate and amphetamine are two separate categories, both efficacious –75% with first trial, 85% with two trials

STIMULANT SIDE EFFECTS Decreased appetite, insomnia, irritability Slightly increased BP and HR 1/400 experience psychosis Some small reduction in ht and wt trajectory while taking them but long term effect unknown May or may not exacerbate a tic Risk of sudden death, stoke or heart attack no higher than in general population

METHYLPHENIDATE PREPARATIONS Short acting: Ritalin (5-60mg/day) Intermediate: Metadate (20-60mg/day) Ritalin LA Long acting: Concerta (18-72mg/day) Focalin XR (5-30mg/day) Daytrana patch (10-30mg/day)

AMPHETAMINE PREPARATIONS Short acting: Dexedrine (5-40mg/day) Intermediate: Adderall (2.5mg-40mg/day) Long acting: Adderall XR (10-40mg/day) Lisdexamphetamine (Vyvanse)(30- 70mg/day)

STIMULANTS Significant abuse potential, especially short acting “pharming” Children with ADHD have a 2.5 fold increase in the risk for any substance abuse disorder including nicotine, alcohol, marijuana, and diversions of prescription medications Research suggests that 16-23% of school- aged children are approached to sell, buy or trade their stimulant medication

STIMULANTS Misuse of stimulant medication common (5- 9% of grade school and high school aged children and 5-35% college aged) Methods to reduce the risk for misuse: long- acting formulations, ensure that the DX is correct, educate family regarding the risks for misuse, provide guidance during the transition of medication from parent to child, using non-stimulant medications

NON-STIMULANTS ATOMOXETINE (Strattera)—norepinephrine re-uptake inhibitor FDA approved for ADHD Good second line choice when stimulants not tolerated or risk of diversion or AODA Not as effective as long-acting stimulants Side Effects: sedation, nausea, poor appetite

ATOMOXETINE Provides 24 hr coverage, effect starts after 2- 4 weeks, 25-100mg/day, can give once a day Black Box warning regarding suicidal ideation

Alpha-2-agonists Centrally acting anti-hypertensive medications FDA approved for ADHD GUANFACINE (1-4mg/day) Intuniv= long acting form Side effects: sedation, orthostatic hypotension CLONIDINE (0.1-0.4mg/day) Long acting form Kapvay Some evidence for combined use with stimulants

NON-FDA APPROVED NON-STIMULANTS Buproprion: helpful with ADHD comorbid with depression. Do not use if seizure history Tri-cyclic antidepressants: need to monitor EKG @ baseline and follow-up, blood levels; weight gain Modafinil: likely mechanism dopamine reo- uptake, not first line med

NON- PHARMACOLOGICAL TREATMENT Cognitive Therapy: specific exercises to train attention, working memory, impulsivity via ongoing feedback to reinforce correct responses Neurofeedback: recent study showed this to be better than CT; in neurofeedback child receives immediate auditory and visual feedback re his level of attention during the exercises; significant improvement sustained over 6 months with reduced med doses; likely due to plasticity in pre-frontal cortex

BEHAVIOR THERAPY Groups, practice, reward Implications for school nurses Questions